These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer. Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines. Suetsugu T; Mori R; Futamura M; Fukada M; Tanaka H; Yasufuku I; Sato Y; Iwata Y; Imai T; Imai H; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yoshida K Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649846 [TBL] [Abstract][Full Text] [Related]
4. Long-term resistance to 5-fluorouracil promotes epithelial-mesenchymal transition, apoptosis evasion, autophagy, and reduced proliferation rate in colon cancer cells. Sousa-Squiavinato ACM; Arregui Ramos DA; Wagner MS; Tessmann JW; de-Freitas-Junior JCM; Morgado-Díaz JA Eur J Pharmacol; 2022 Oct; 933():175253. PubMed ID: 36067803 [TBL] [Abstract][Full Text] [Related]
5. Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota. Sougiannis AT; VanderVeen BN; Enos RT; Velazquez KT; Bader JE; Carson M; Chatzistamou I; Walla M; Pena MM; Kubinak JL; Nagarkatti M; Carson JA; Murphy EA Brain Behav Immun; 2019 Aug; 80():44-55. PubMed ID: 30807838 [TBL] [Abstract][Full Text] [Related]
6. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer. Yoshida Y; Wang IC; Yoder HM; Davidson NO; Costa RH Gastroenterology; 2007 Apr; 132(4):1420-31. PubMed ID: 17408638 [TBL] [Abstract][Full Text] [Related]
7. Annexin A1 is involved in resistance to 5-FU in colon cancer cells. Onozawa H; Saito M; Saito K; Kanke Y; Watanabe Y; Hayase S; Sakamoto W; Ishigame T; Momma T; Ohki S; Takenoshita S Oncol Rep; 2017 Jan; 37(1):235-240. PubMed ID: 27840982 [TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 1A1 is essential for the microbial metabolite, Urolithin A-mediated protection against colitis. Ghosh S; Moorthy B; Haribabu B; Jala VR Front Immunol; 2022; 13():1004603. PubMed ID: 36159798 [TBL] [Abstract][Full Text] [Related]
9. Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis. Touil Y; Igoudjil W; Corvaisier M; Dessein AF; Vandomme J; Monté D; Stechly L; Skrypek N; Langlois C; Grard G; Millet G; Leteurtre E; Dumont P; Truant S; Pruvot FR; Hebbar M; Fan F; Ellis LM; Formstecher P; Van Seuningen I; Gespach C; Polakowska R; Huet G Clin Cancer Res; 2014 Feb; 20(4):837-46. PubMed ID: 24323901 [TBL] [Abstract][Full Text] [Related]
10. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancer. Zhao Y; Wang C; Goel A Carcinogenesis; 2021 Jun; 42(6):814-825. PubMed ID: 33822896 [TBL] [Abstract][Full Text] [Related]
11. Forkhead box O3 promotes colon cancer proliferation and drug resistance by activating MDR1 expression. Gao Z; Li Z; Liu Y; Liu Z Mol Genet Genomic Med; 2019 Mar; 7(3):e554. PubMed ID: 30623608 [TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effects of ZD0473 (AMD473) in combination with 5-fluorouracil or SN38 in human colorectal cancer cell lines. Plasencia C; Abad A; Martinez-Balibrea E; Taron M Invest New Drugs; 2004 Nov; 22(4):399-409. PubMed ID: 15292710 [TBL] [Abstract][Full Text] [Related]
13. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon. Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258 [TBL] [Abstract][Full Text] [Related]
14. IRE1α-targeting downregulates ABC transporters and overcomes drug resistance of colon cancer cells. Gao Q; Li XX; Xu YM; Zhang JZ; Rong SD; Qin YQ; Fang J Cancer Lett; 2020 Apr; 476():67-74. PubMed ID: 32061752 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1. Liu X; Xie T; Mao X; Xue L; Chu X; Chen L Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661 [TBL] [Abstract][Full Text] [Related]
16. Urolithin A attenuates arsenic-induced gut barrier dysfunction. Ghosh S; Banerjee M; Haribabu B; Jala VR Arch Toxicol; 2022 Apr; 96(4):987-1007. PubMed ID: 35122514 [TBL] [Abstract][Full Text] [Related]
17. Beta-Hydroxybutyrate Promotes Proliferation, Migration and Stemness in a Subpopulation of 5FU Treated SW480 Cells: Evidence for Metabolic Plasticity in Colon Cancer. Shakery A; Pourvali K; Ghorbani A; Fereidani SS; Zand H Asian Pac J Cancer Prev; 2018 Nov; 19(11):3287-3294. PubMed ID: 30486639 [TBL] [Abstract][Full Text] [Related]
18. Co-administration of 5FU and propolis on AOM/DSS induced colorectal cancer in BALB-c mice. Sameni HR; Yosefi S; Alipour M; Pakdel A; Torabizadeh N; Semnani V; Bandegi AR Life Sci; 2021 Jul; 276():119390. PubMed ID: 33794252 [TBL] [Abstract][Full Text] [Related]
19. 5‑FU resistance abrogates the amplified cytotoxic effects induced by inhibiting checkpoint kinase 1 in p53‑mutated colon cancer cells. Akasaka T; Tsujii M; Kondo J; Hayashi Y; Ying J; Lu Y; Kato M; Yamada T; Yamamoto S; Inoue T; Tsujii Y; Maekawa A; Fujinaga T; Shiraishi E; Hiyama S; Inoue T; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T Int J Oncol; 2015 Jan; 46(1):63-70. PubMed ID: 25310623 [TBL] [Abstract][Full Text] [Related]
20. Urolithin A Alleviates Colitis in Mice by Improving Gut Microbiota Dysbiosis, Modulating Microbial Tryptophan Metabolism, and Triggering AhR Activation. Ma M; Wang Y; Fan S; Huang Y; Su X; Lu C J Agric Food Chem; 2023 May; 71(20):7710-7722. PubMed ID: 37167350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]